40 Stocks Moving In Friday's Mid-Day Session

Gainers

• India Globalization Capital, Inc. IGC climbed 65.6 percent to $3.56 after surging 27.22 percent on Thursday.
• Y-mAbs Therapeutics, Inc. YMAB shares gained 63.3 percent to $26.12. Y-mAbs priced its IPO at $16 per share.
• Cool Holdings, Inc. AWSM shares climbed 28.8 percent to $13.52 after surging 53.28 percent on Thursday.
• Oasmia Pharmaceutical AB OASM shares climbed 25.8 percent to $3.22 after dropping 6.91 percent on Thursday.
• Energy XXI Gulf Coast, Inc. EGC gained 20.4 percent to $7.44 after issuing statement related to merger with affiliates of Cox Oil.
• Steelcase Inc. SCS jumped 15.2 percent to $18.60 after the company reported better-than-expected earnings for its second quarter. The company issued strong Q3 and FY19 earnings guidance.
• KalVista Pharmaceuticals, Inc. KALV rose 12.3 percent to $20.22.
• Electrameccanica Vehicles Corp. SOLO gained 11 percent to $2.6867.
• Altimmune, Inc. ALT gained 10.5 percent to $28.97.
• Mazor Robotics Ltd. MZOR rose 10.1 percent to $58.06 after Medtronic PLC MDT announced a deal to buy Mazor Robotics for $58.59 per ADS, or $29.25 per ordinary share, in cash for a total value of $1.64 billion, or $1.34 billion, net of Medtronic's existing stake in Mazor and cash acquired.
• Puxin Limited NEW shares rose 9 percent to $9.0564.
• Ladenburg Thalmann Financial Services Inc. LTS shares gained 8.9 percent to $2.58. Ladenburg named CEO Richard Lampen as Chairman of the Board.
• Blue Hills Bancorp, Inc. BHBK shares climbed 8.7 percent to $25.60. Independent Bank Corp subsidiary Rockland Trust announced plans to acquire Blue Hills Bancorp.
• PPDAI Group Inc. PPDF gained 7.3 percent to $6.32 after the company reported changes in board of directors.
• Novavax, Inc. NVAX climbed 7.2 percent to $1.58. JP Morgan upgraded Novavax from Underweight to Overweight.
• Lithia Motors, Inc. LAD gained 5.2 percent to $88.59. Guggenheim upgraded Lithia Motors from Neutral to Buy.

Check out these big penny stock gainers and losers

Losers

• GTx, Inc. GTXI shares tumbled 92.1 percent to $1.86 after top-line results from the company's ASTRID trial of Enobosarm for women with stress urinary incontinence did not achieve statistical significance in its primary endpoint.
• Titan Pharmaceuticals, Inc. TTNP declined 55.6 percent to $0.2221. Titan Pharma priced its underwritten public offering, with the offering expected to generate gross proceeds of $9.5 million.
• Bio-Path Holdings Inc BPTH fell 37.5 percent to $0.6001 after the company reported the issuance and sale of 2.261 million shares at $0.65 per share.
• Tilray, Inc. TLRY shares fell 27.2 percent to $128.50 after dropping 17.62 percent on Thursday.
• Avino Silver & Gold Mines Ltd ASM shares dropped 24.3 percent to $0.5962 after reporting a common stock offering.
• Pier 1 Imports Inc PIR shares fell 23.8 percent to $1.38 after reporting weak preliminary earnings results for its second quarter. The company expects Q2 loss of $0.64 to $0.62 per share and comparable sales to drop around 11.4 percent year-over-year.
• New Age Beverages Corporation NBEV shares dropped 23.5 percent to $5.9995 after climbing 79.63 percent on Thursday.
• DAVIDsTEA Inc. DTEA climbed 20.2 percent to $2.675 after gaining 11.67 percent on Thursday.
• Revlon, Inc. REV shares dropped 16.5 percent to $20.20.
• Therapix Biosciences Ltd. TRPX shares fell 15.6 percent to $4.83 after surging 34.91 percent on Thursday.
• Ur-Energy Inc. URG shares fell 15.2 percent to $0.786 after reporting a common stock offering.
• Corbus Pharmaceuticals Holdings, Inc. CRBP shares dipped 14.8 percent to $6.7726.
• Youngevity International, Inc. YGYI shares fell 13.3 percent to $5.11.
• United Natural Foods, Inc. UNFI fell 12.5 percent to $29.61 after the company reported weaker-than-expected results for its fourth quarter.
• Veritiv Corporation VRTV dipped 12.1 percent to $39.30. Veritiv priced its 1.5 million share secondary offering of common stock by UWW Holdings.
• Aytu BioScience, Inc. AYTU dropped 11.2 percent to $3.0201.
• Dunxin Financial Holdings Limited DXF shares declined 10.7 percent to $4.333.
• Ossen Innovation Co., Ltd. OSN shares 10.2 percent to $2.20.
• Biocept, Inc. BIOC dipped 9.3 percent to $3.03 after the company reported the pricing of $2.5 million registered direct offering priced at the market.
• Intellia Therapeutics, Inc. NTLA shares fell 9.3 percent to $28.58.
• Galectin Therapeutics, Inc. GALT dropped 8.1 percent to $6.3699.
• Crispr Therapeutics AG CRSP fell 7.7 percent to $45.24. Crispr Therapeutics announced it has priced its underwritten public offering of 4.21 million shares at $47.50 per share, a discount to Thursday's closing price of $48.99.
• Mechel PAO MTL fell 7.6 percent to $3.16 after rising 17.12 percent on Thursday.
• Western Asset Mortgage Capital Corporation WMC fell 6.2 percent to $10.61 after reporting a 6.5 million share common stock offering.